Nancy Duarte-Lonnroth
Geen lopende functies
Loopbaan van Nancy Duarte-Lonnroth
Eerdere bekende functies van Nancy Duarte-Lonnroth
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ACER THERAPEUTICS INC. | Corporate Officer/Principal | 01-05-2018 | - |
| CELESTICA INC. | Algemeen Adviseur | 04-02-2010 | - |
| Corporate Officer/Principal | 18-03-2013 | 20-03-2013 |
Opleiding van Nancy Duarte-Lonnroth
| University of Massachusetts | Graduate Degree |
| Franklin Pierce University | Masters Business Admin |
Statistieken
Internationaal
| Verenigde Staten | 4 |
| Canada | 2 |
Operationeel
| Corporate Officer/Principal | 2 |
| General Counsel | 1 |
| Graduate Degree | 1 |
Sectoraal
| Consumer Services | 3 |
| Electronic Technology | 2 |
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CELESTICA INC. | Electronic Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Acer Therapeutics, Inc.
 Acer Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Acer Therapeutics, Inc. is a pharmaceutical company, which engages in the acquisition, development, and commercialization of therapies for medical needs. Its product pipeline includes Olpruva, Edsivo, and ACER-801. Olpruva is used for the treatment of urea cycle disorders. Edsivo is a type of celiprolol used in treating Vascular Ehlers-Danlos syndrome. ACER-001 treats menopausal related Vasomotor symptoms. The company was founded by Chris Schelling on March 15, 1991 and is headquartered in Newton, MA. | Health Technology |
